February 2017

The Indian pharmaceutical market, attached to sales of more than Rs lakh 1 crore each year, is one of the largest and fastest growing markets worldwide. Given the highly fragmented marketplace, government and regulators have faced a challenge to curb unethical practices, which in turn grow rapidly in the absence of rigorous regulation.

In a letter to Prime Minister Narendra Modi, the Alliance of Doctors for Ethical  Healthcare (ADEH) said that these drugs and implants are also accused of "exorbitantly" like coronary stents. ADEH has also attached documents to show how drug providers, especially those for cancer, and knee and hip replacement implants are exorbitant prices, sometimes 200 percent more than the actual price.